Flanigan and colleagues report the results of an intravenous dose-escalation study using an AAV9-encapsidated U7snRNA vector to skip DMD exon 2 and restore dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy. Here, DMD is linked to Duchenne muscular dystrophy.